Private Equity Surge Raises Concerns Over Hospital Costs in India
TL;DR
- Private equity is increasingly investing in Indian hospitals, pharma, insurance and labs
- Regulatory oversight remains limited, creating affordability issues
- Author Ameer Shahul warns of potential impacts on patient accountability
Ameer Shahul, a public‑policy expert, discusses how private equity capital is rapidly acquiring assets across India's healthcare sector, including hospitals, pharmaceutical firms, insurers and diagnostic laboratories.
He notes that this expansion is occurring amid a regulatory vacuum, which he says leaves patients vulnerable to higher costs and reduced accountability.
Shahul's new book, titled “The Silent Syndicate: How Big Finance is Destroying India’s Healthcare,” examines these trends and calls for measures to ensure that privatized healthcare remains affordable and answerable to patients.
Why It Matters
The growing influence of private equity on India's healthcare system could affect Indian expatriates and their families in the U.S., Canada, and India by potentially increasing out‑of‑pocket medical expenses and limiting affordable care options, highlighting the need for stronger regulatory frameworks.
Oct 31, 2026 · Updated 10/31/2026, 12:55:27 PM · Reported with: The Hindu
Sources (1)
NRI Bytes writes its own articles from the reporting below.
The Hindu — How Private Equity Is Driving Up Your Hospital Bills | In Focus WeekendUp next · Health
Preparing for the End of Daylight Saving Time
Read next →
